Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
about
Genetic testing for prevention of severe drug-induced skin rashFever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityComparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug ReactionsReal-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivityPharmGKB summary: very important pharmacogene information for human leukocyte antigen B.HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese.HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysisApproach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.Seizure management in patients with gliomas.Pharmacogenetics of antiepileptic drug-induced hypersensitivity.Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms.Pharmacogenomics and Implications for Nursing Practice.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.Early toxic epidermal necrolysis syndrome post-intra-cranial tumor resection.Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology.Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature.The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions.In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug UsageIs Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia.HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions.CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug-drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital.Association of CYP2C9*3 with phenytoin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis.HLA Association with Drug-Induced Adverse Reactions.HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.History repeats itself: the family medication history and pharmacogenomics.Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs.Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
P2860
Q24202114-338213A6-9BC2-43EF-BAC8-B086B3B0D3E0Q27692095-11D043BA-8C83-4570-9BB3-462B4AAE7ACDQ28080256-39B0842C-3347-4DF0-AE35-ADF1FA9C04F4Q28552275-32866B33-FACE-4637-8FB1-B43B92F6A969Q33578364-73EFA433-54A5-4D17-98BF-7A309F863193Q33666857-4D54FDBD-FA53-4192-9084-AA847EDCB6E1Q33671281-65102BD1-2DC3-4CE3-BE73-F0C7D8F19627Q34999573-8659BB44-B0D5-4B72-B9A0-EB39222711C5Q35168561-68BACFDD-67CC-4F97-B34B-5AFA29F49EFFQ35555607-C35A5648-5E39-43FF-8ECC-E648AEF19C08Q36327874-99FD72C2-F155-46E6-8972-1B01723C7BBDQ37695437-ECE7FDD6-4B3F-424B-9341-6C3BB9C31609Q38189495-B2265571-238F-4E8D-A4F0-288F4FBF9955Q38217627-7C260183-F995-4753-96B3-D7D4BC4B5EDFQ38222509-52DDA425-D0FF-4854-9F04-4FBE6F766137Q38391340-76234B2D-789A-41DE-B13B-C5A849340020Q38457053-CD73A6E1-C725-4DC7-8730-B6D530B8B83CQ38607878-A1DDB274-181F-4F9F-B3B5-6C4480405DE6Q38611191-F4497399-05F7-4747-8F8B-47FE7585A691Q38667195-D41AABE8-C993-4951-AB11-9968861A44F6Q39074126-9D52E651-0314-4FA1-BCA8-6621FA5469DFQ39103035-7BC314EC-4A01-42FD-A010-29BB0DC752E7Q39359391-BE1A3EC4-C703-42C3-AC51-ED7221652618Q39370823-8668085A-ED95-4D55-ABCE-23AA5C9FF67EQ39427540-E4A7855A-FC18-42E0-8EE4-9186A5144571Q39909074-5883CA76-DDB1-4626-BCE3-DA5F4940ABB7Q39941531-2A66055C-94FC-4ED0-8CB5-3B08FCD4057CQ40271934-2EDEC928-F7B0-4905-A43E-90DF464C757AQ40984481-B940EFD9-8802-4473-9E5C-4F6612033B7FQ42005025-1296EC39-05A3-4B66-B41E-A3B0EE2C2E6EQ42339143-42699F73-3DDD-4592-9089-035530B41D70Q47254975-8B8482A2-DF3D-4E82-BC2F-80D76CD8BDECQ47553722-B5DE4ABB-1E81-4C71-B657-4679CC94F5EBQ47826173-E687C85A-369E-48C8-994E-AA92430CB838Q50094090-C92F5EE1-D8E3-43B7-A870-3CC809A43EB4Q50102015-377B8EA5-A7E4-4A92-BB28-9D26FC899E3CQ50856364-4025B557-536F-41D6-9F49-F70BA3B61093Q54094996-270A2CA1-7769-4502-8D4E-16FD4E8E49A0Q55324381-2F322614-A1CD-462F-A8CD-ECE0892D1A3B
P2860
Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Relationship between the HLA-B ...... atic review and meta-analysis.
@ast
Relationship between the HLA-B ...... atic review and meta-analysis.
@en
Relationship between the HLA-B ...... atic review and meta-analysis.
@nl
type
label
Relationship between the HLA-B ...... atic review and meta-analysis.
@ast
Relationship between the HLA-B ...... atic review and meta-analysis.
@en
Relationship between the HLA-B ...... atic review and meta-analysis.
@nl
prefLabel
Relationship between the HLA-B ...... atic review and meta-analysis.
@ast
Relationship between the HLA-B ...... atic review and meta-analysis.
@en
Relationship between the HLA-B ...... atic review and meta-analysis.
@nl
P2093
P1433
P1476
Relationship between the HLA-B ...... atic review and meta-analysis.
@en
P2093
Manupat Lohitnavy
Nathorn Chaiyakunapruk
Ratchadaporn Somkrua
Wichittra Tassaneeyakul
Wimonchat Tangamornsuksan
P304
P356
10.1001/JAMADERMATOL.2013.4114
P407
P577
2013-09-01T00:00:00Z